Authors
Latest:
A Fork in the Road: The Community Pharmacy PerspectiveThe particular skill set of the pharmacist is more fully utilized when the quality of care provided is valued over the quantity of prescriptions filled.
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
New Antimicrobials Expand Treatment OptionsEravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
Latest:
Pharmacists Can Help Assess New FDA-Approved IV OpioidOliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.
Latest:
The Impact of Coronavirus on Pharmacy Students Beginning APPE RotationsStudent pharmacists across the country have had to adjust their expectations of what P4 year will look like.
Latest:
Novel Drug May Help Reduce Tumor Growth, Slow Progression of Liver CancerResearchers have developed a novel peptide drug called FFW that could potentially reduce tumor growth and slow progression of liver cancer.
Latest:
Utilizing Pharmacogenomics Information to Guide AML TreatmentThere are specific treatment options patients may qualify for depending on the cytogenetic or molecular abnormality detected.
Latest:
First-in-Class Immunotoxin Shows Durable Response in Hairy Cell LeukemiaMoxetumomab pasudotox is a nonchemotherapeutic drug that could become the standard of care for patients with relapsed/refractory hairy cell leukemia.
Latest:
Challenges in Brand Strategies for Tweener ProductsThe best patient and provider experience will result in a coordination of efforts across the channel continuum.
Latest:
Pharmacy Residency Is Not the End-All-Be-All for Pharmacy StudentsAlthough a residency is beneficial for traditional career paths, a career can be more than working inside a pharmacy.
Latest:
Weave Pharmacogenomics Drug-Gene Interactions Into MTMKeep a critical eye on whether precautions should be taken or a change in therapy is warranted.
Latest:
Increases in Utilization Management of Oncology Medicines by US PayersRecent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
Latest:
Postnasal DripExperts answer questions to help provide relief for those suffering with postnasal drip.
Latest:
How Government Pricing Professionals Became Pharmaceutical Industry Change AgentsThe world of government pricing (GP), once a mystery to many in the pharmacy industry, is considered to be a key component of strategic and compliance activity. For pharmaceutical manufacturers, government business is a top priority.
Latest:
Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty PracticeWhile warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.
Latest:
Progress in Treating Advanced Melanoma: Pharmacists' Roles in Improving OutcomesProgress in Treating Advanced Melanoma: Pharmacists’ Roles in Improving Outcomes
Latest:
Adult Immunizations: Are Your Patients Up-to-Date?In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Latest:
Community “Specialty†Pharmacy vs the CompetitionGiven the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.
Latest:
Neostigmine Methylsulfate Injection (Bloxiverz)Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.
Latest:
Implementation Strategy to Bring Medication Therapy Management Into High-ÂVolume Community PharmaciesThis study shows how medication therapy management can be integrated into challenging pharmacy work flow, and also assesses the resulting benefits, both clinical and financial.
